Gemcitabine/carboplatin in a modified 21-day administration schedule for advanced-stage non-small-cell lung cancer.

Yoshimura, Mana; Imamura, Fumio; Ueno, Kiyonobu; Uchida, Junji

Yoshimura, Mana; Imamura, Fumio; Ueno, Kiyonobu; Uchida, Junji.

Affiliation

Yoshimura M; Osaka Medical Center for Cancer and Cardiovascular Diseases, Japan.

Clin Lung Cancer ; 8(3): 208-13, 2006 Nov.

Article in En | MEDLINE | ID: mdl-17239297

Subject(s)

Adenocarcinoma/drug therapy; Antineoplastic Combined Chemotherapy Protocols/administration & dosage; Carboplatin/administration & dosage; Carcinoma, Squamous Cell/drug therapy; Deoxycytidine/analogs & derivatives; Lung Neoplasms/drug therapy; Adenocarcinoma/mortality; Adult; Aged; Area Under Curve; Carboplatin/adverse effects; Carcinoma, Squamous Cell/mortality; Deoxycytidine/administration & dosage; Deoxycytidine/adverse effects; Drug Administration Schedule; Female; Humans; Lung Neoplasms/mortality; Male; Middle Aged; Neoplasm Staging; Thrombocytopenia/chemically induced; Treatment Outcome; Gemcitabine

Search on Google

Add to My VHL

XML

PubMed Links

Database: MEDLINE Main subject: Carcinoma, Squamous Cell / Adenocarcinoma / Antineoplastic Combined Chemotherapy Protocols / Carboplatin / Deoxycytidine / Lung Neoplasms Type of study: Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Clin Lung Cancer Journal subject: NEOPLASIAS Year: 2006 Type: Article Affiliation country: Japan

Search on Google

Add to My VHL

XML

PubMed Links